People
Rentschler Biopharma SE, a world-class contract development and manufacturing organization for biopharmaceuticals, announced that its Chairman of the Board, Prof. Dr. Nikolaus F. Rentschler, together with CEO Dr. Frank Mathias have received the “EY Entrepreneur of the Year” Award 2019 in the category Industry.
Bit bio, a Cambridge University startup, added a number of industry luminaries to its leadership team to support its moonshot goal of developing a scalable platform technology capable of producing any human cell type.
Michigan State University researchers Sophia Lunt and Richard Lunt, a married couple, work in different departments, but have found a common ground that could lead to cancer diagnostics and therapies.
The Society for Medical Decision Making awarded Regenstrief Institute researcher Stephen Downs, M.D., M.S., with the John M. Eisenberg Award for Practical Application of Medical Decision Making Research.
EVERSANATM, the leading independent provider of global commercial services to the life science industry, today appointed oncology veteran Suzanne Greenwood, RN, BSN, to Senior Vice President, Commercial Solutions.
The members of the Nomination Committee for the Annual General Meeting of Bactiguard Holding AB (publ), to be held on Tuesday 28 April 2020 at the company’s headoffice in Botkyrka, have now been appoined.
Pharma and life sciences companies strengthen their executive and leadership teams with this week’s appointments.
Acorda Therapeutics will terminate approximately 25% of its headcount as the company initiates a corporate restructuring only weeks after being snubbed by the U.S. Supreme Court over a patent appeal for multiple sclerosis drug Ampyra.
The five scientists on this list collectively made many exciting strides in the field, notably because they had the technological skills to embrace and utilize advances in the realm of computer programming.
Kiadis Pharma N.V. announces the formation of its Scientific Advisory Board comprised of world-leading experts in the field of oncology and cell therapy.
PRESS RELEASES